Substituting nevirapine for protease inhibitors because of intolerance

被引：13

作者：

Dieleman, JP ^{[1
]}

Gyssens, IC

Sturkenboom, MJCM

Niesters, HGM

van der Ende, ME

机构：

[1] Erasmus Univ, Med Ctr, Dept Internal Med, Pharmacoepidemiol Unit, Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Biostat & Epidemiol, Pharmacoepidemiol Unit, Rotterdam, Netherlands

[3] Erasmus Univ, Med Ctr, Dept Microbiol & Infect Dis, Rotterdam, Netherlands

[4] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands

[5] Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands

来源：

AIDS | 1999年 / 13卷 / 11期

关键词：

D O I：

10.1097/00002030-199907300-00029

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1423 / 1424

页数：2

共 6 条

[1] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].

Carr, A ;

Samaras, K ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1998, 351 (9119) :1881-1883

[2] HIV-1 protease inhibitors - A review for clinicians [J].

Deeks, SG ;

Smith, M ;

Holodniy, M ;

Kahn, JO .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153

[3] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy [J].

Havlir, DV ;

Marschner, IC ;

Hirsch, MS ;

Collier, AC ;

Tebas, P ;

Bassett, RL ;

Ioannidis, JPA ;

Holohan, MK ;

Leavitt, R ;

Boone, G ;

Richman, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1261-1268

[4] A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].

Montaner, JSG ;

Reiss, P ;

Cooper, D ;

Vella, S ;

Harris, M ;

Conway, B ;

Wainberg, MA ;

Smith, D ;

Robinson, P ;

Hall, D ;

Myers, M ;

Lange, JMA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937

[5] A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients [J].

Pialoux, G ;

Raffi, F ;

Brun-Vezinet, F ;

Meiffrédy, V ;

Flandre, P ;

Gastaut, JA ;

Dellamonica, P ;

Yeni, P ;

Delfraissy, JF ;

Aboulker, JP .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1269-1276

[6] Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study [J].

Reijers, MHE ;

Weverling, GJ ;

Jurriaans, S ;

Wit, FWNM ;

Weigel, HM ;

Ten Kate, RW ;

Mulder, JW ;

Frissen, PHJ ;

van Leeuwen, R ;

Reiss, P ;

Schuitemaker, H ;

de Wolf, F ;

Lange, JMA .

LANCET, 1998, 352 (9123) :185-190

← 1 →